In recent weeks, we have made calls alongside our colleagues in OACS Ireland for an Independent Inquiry for famiiies affected by Sodium Valproate (Epilim) where the drug was prescribed to women of child-bearing age. The effects of exposure to sodium valproate in utero are well documented, with 30-40% of children exposed to valproate being born with a neurodevelopmental condition and 10% being born with a congenital malformation.
The European Federaton of Neurological Associations have published the findings from their recent international survey on stigma experienced by those living with a neurological condition across Europe.
We recently shared the survey across our social media channels and we would like to thank everyone who took the time to take part.
A major international study based in Ireland has reported exciting new discoveries which could lead to the development of new drugs to treat epilepsy.
The findings of the study are the culmination of seven years of research involving 35 scientists across eight European countries and was co-ordinated right here in Ireland by both FutureNeuro and the RCSI.
Epilepsy Ireland are currently seeking candidates for the post of Community Resource Officer for the North Cork Region. Our team of Community Resource Officers are the front line of our service who provide support and advice for people with epilepsy and their families on how best to manage their condition.
The closing date for receipt of applications is 5pm on Wednesday 12th August 2020 with interviews set to be held during the week of the 24th August.